Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE2V.L Regulatory News (E2V)

  • There is currently no data for E2V

Prospectus Clarification

6 Nov 2009 13:12

RNS Number : 1310C
e2v technologies PLC
06 November 2009
 



PRESS RELEASE

06 November 2009

e2v technologies PLC Re: Prospectus

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. NOTHING IN THIS ANNOUNCEMENT IS AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES OR ANY OTHER RESTRICTED JURISDICTION OF ANY SECURITIES REFERENCE HEREIN. SUCH SECURITIES MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION OR AN EXEMPTION FROM REGISTRATION UNDER THE US SECURITIES ACT OF 1933, AS AMENDED. NO PUBLIC OFFERING OF THE SECURITIES IS BEING OR WILL BE MADE IN THE UNITED STATES. 

e2v technologies plc (the "Company")

The Company wishes to announce a clarification in respect of a statement contained in the prospectus dated 2 November 2009 (the "Prospectus") relating to the proposed Firm Placing of 31,428,571 Firm Placed Shares at 70 pence per Firm Placed Share and 9 for 7 Rights Issue of 120,854,782 New Shares at 28 pence per share.

Pages 6 and 38 of the Prospectus contain the following identical statement in relation to Related Party Transactions as follows:

"Aberforth is considered to be a related party to the Company because the aggregate shareholding of it and its associates is in excess of 10% of the Company's existing issued share capital. Aberforth has undertaken to participate in the Firm Placing through the acquisition of 6,800,514 Firm Placed Shares and to take up its rights under the Rights Issue."

The Company wishes to clarify that Aberforth has undertaken to take up those rights arising from the acquisition of 6,800,514 Firm Placed Shares but has not given any undertaking in relation to rights over its existing Shares.

Terms defined in the Prospectus have the same meanings in this announcement. 

THIS ANNOUNCEMENT SHALL NOT CONSTITUTE, OR FORM PART OF, AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES, NOR SHALL THERE BE ANY SALE OR PURCHASE OF SECURITIES IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SWITZERLAND OR ANY JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH JURISDICTION. THE AVAILABILITY OF THE FIRM PLACING AND THE RIGHTS ISSUE TO PERSONS NOT RESIDENT IN THE UNITED KINGDOM MAY BE AFFECTED BY THE LAWS OF THE RELEVANT JURISDICTIONS. SUCH PERSONS SHOULD INFORM THEMSELVES ABOUT AND OBSERVE ANY APPLICABLE REQUIREMENTS. 

 

 

This announcement is not for publication, distribution or release to persons in the United StatesAustraliaCanadaJapanNew ZealandSouth Africa or Switzerland and should not be distributed, forwarded to or transmitted in or into any jurisdiction where to do so might constitute a violation of local securities laws or regulations. The securities discussed herein have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act") and may not be offered, sold, resold, taken up, exercised, renounced, transferred or delivered, directly or indirectly, in or into the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act. No public offering of the securities referred to herein is being made in the United States. This announcement is an advertisement and does not constitute a prospectus. Nothing in this announcement should be interpreted as a term or condition of the Firm Placing or the Rights Issue. Any decision to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any Firm Placed Shares, Nil Paid Rights, Fully Paid Rights and/or New Shares must be made only on the basis of the information contained in and incorporated by reference into the Prospectus. 

e2v technologies plc:
 
Keith Attwood, Chief Executive
Charles Hindson, Group Finance Director
 
01245 493 493
 
 
 
Rothschild (Sponsor and Financial Adviser): 
 
Nigel Himsworth
Roger Hemming
John Byrne
 
0207 280 5000
 
 
 
RBS Hoare Govett Limited (Bookrunner and Underwriter): 
 
Corporate Broking: 
John MacGowan
Alexander Garton
Syndication:
Lee Morton
 
0207 678 8000
 
 
 
Financial Dynamics
 
Susanne Yule
Sophie Kernon
 
0207 831 3113 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PDIILFIVLDLRIIA
Date   Source Headline
22nd Sep 20112:09 pmRNSHolding(s) in Company
12th Sep 20115:02 pmRNSTotal Voting Rights
8th Aug 20113:52 pmRNSHolding(s) in Company
4th Aug 20117:00 amRNSVermiculite Processing System Field Trial
28th Jul 20117:00 amRNSNew Banking Facilities
27th Jul 20114:28 pmRNSResult of AGM
15th Jul 201110:17 amRNSHolding(s) in Company
8th Jul 201110:47 amRNSStatement Re Boiler Room Scams
8th Jun 20113:46 pmRNSTotal Voting Rights
6th Jun 20114:49 pmRNSFinal Dividend Timetable
6th Jun 20117:00 amRNSFinal Results
27th May 20119:45 amRNSHolding(s) in Company
21st Apr 20111:55 pmRNSTotal Voting Rights
21st Apr 201112:56 pmRNSDirector/PDMR Shareholding
12th Apr 20113:00 pmRNSe2v awarded up to £6.2m development grant
11th Apr 20117:00 amRNSYear end trading update & dividend declaration
4th Mar 201110:30 amRNSHolding(s) in Company
22nd Feb 20113:45 pmRNSHolding(s) in Company
2nd Feb 20112:00 pmRNSDirector/PDMR Shareholding
31st Jan 20117:00 amRNSInterim Management Statement
28th Jan 20111:30 pmRNSDirectorate Change
20th Jan 20112:30 pmRNSBank arrangements concerning dividends
6th Dec 20104:57 pmRNSTotal Voting Rights
19th Nov 20103:21 pmRNSHolding(s) in Company
18th Nov 201012:12 pmRNSChange of Director's Details
17th Nov 20104:40 pmRNSHolding(s) in Company
15th Nov 20107:00 amRNSHalf Yearly Report
9th Nov 201012:11 pmRNSHolding(s) in Company
28th Oct 20107:00 amRNSAppointment of New Non Executive Director
12th Oct 201012:15 pmRNSHolding(s) in Company
11th Oct 20107:00 amRNSPeriod end update
7th Sep 20107:00 amRNSUpdate on Restructuring
25th Aug 201010:40 amRNSHolding(s) in Company
11th Aug 201011:15 amRNSHolding(s) in Company
4th Aug 20108:45 amRNSAwards under Long Term Incentive Plan
29th Jul 20102:57 pmRNSAGM Statement
26th Jul 20107:00 amRNSStrategy Briefing
23rd Jul 201012:42 pmRNSTotal Voting Rights
19th Jul 20107:00 amRNSInterim Management Statement
14th Jul 201010:15 amRNSHolding(s) in Company
21st Jun 20104:35 pmRNSPrice Monitoring Extension
4th Jun 201011:38 amRNSHolding(s) in Company
17th May 201012:53 pmRNSTotal Voting Rights
10th May 20107:00 amRNSAppointment of corporate broker
7th May 20102:00 pmRNSHolding(s) in Company
4th May 20101:35 pmRNSHolding(s) in Company
29th Apr 20109:19 amRNSAdditional Listing
28th Apr 20103:40 pmRNSHolding(s) in Company
12th Apr 20107:00 amRNS2010 Year End Trading update
7th Apr 20109:20 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.